TPB — Turning Point Brands, Inc.
NYSE
Q4 2025 Earnings Call Summary
March 2, 2026
TPB Q4 2025 Earnings Call Summary
1. Key Financial Results and Metrics:
- Revenue: Increased by 29% year-over-year to $121 million.
- Adjusted EBITDA: Rose 14% to $30 million, with a margin of 24.8%.
- Gross Margin: Maintained at 55.9%, flat compared to the previous year.
- SG&A Expenses: Reported at $47.7 million, up $3.1 million sequentially due to increased investments in sales and marketing.
- Free Cash Flow: $19.2 million for the quarter.
- Cash Position: Ended the quarter with $222.8 million in cash.
2. Strategic Updates and Business Highlights:
- Modern Oral Segment: Net revenue from Modern Oral (white nicotine pouches) reached $41.3 million, a 266% increase year-over-year. This segment now accounts for 34% of consolidated net sales.
- Stoker's Segment: Experienced a 70% increase in net sales to $81 million, with legacy brands growing by 9%.
- Zig-Zag Segment: Revenue declined by 13% to $40 million, consistent with expectations as focus shifted to Modern Oral.
- Sales and Marketing Investments: Significant investments are being made to support the growth of FRE and ALP brands, including expanding distribution and enhancing brand presence.
- Manufacturing Expansion: Progress on domestic production with expectations to qualify initial production lines in the coming months.
3. Forward Guidance and Outlook:
- 2026 Guidance for Modern Oral: Gross revenue expected to be between $220 million and $240 million, with net revenue guidance of $180 million to $190 million.
- Q1 2026 EBITDA Forecast: Anticipated between $24 million and $27 million, factoring in increased investments for the white pouch brands.
- CapEx for 2026: Projected between $4 million and $5 million, excluding Modern Oral-related projects.
4. Bad News, Challenges, or Points of Concern:
- Zig-Zag Decline: The decline in Zig-Zag revenue could signal challenges in the legacy brand segment.
- Margin Pressures: Elevated tariff rates impacted Stoker's margins, particularly related to white pouch products.
- Investment Timing: The company acknowledged that investments in sales and marketing may be lumpy throughout the year, creating uncertainty in financial projections.
- Competitive Pressures: The nicotine pouch market is expected to become increasingly competitive, with larger players introducing new products.
5. Notable Q&A Insights:
- Sales and Marketing Investments: Management emphasized the need for upfront investment to successfully launch ALP in brick-and-mortar stores, expected in Q2 2026.
- Domestic Production Outlook: The company is optimistic about domestic production capabilities, which are expected to enhance margins by year-end.
- Distribution Opportunities: There is significant potential for growth in both FRE and ALP distribution, with a focus on maximizing shelf space in existing stores.
- Innovation in the Category: While the company is focused on current product performance, there is recognition of the need for future innovation to stay competitive.
- Tax Landscape: Management noted that potential tax hikes on nicotine pouches would impact all players equally, suggesting a level playing field.
Overall, TPB's Q4 2025 results reflect strong growth in its Modern Oral segment and strategic investments aimed at long-term brand development, despite facing challenges in legacy brands and potential competitive pressures in the market.
